|

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

RECRUITINGPhase 4Sponsored by Konkuk University Medical Center
Actively Recruiting
PhasePhase 4
SponsorKonkuk University Medical Center
Started2026-03-27
Est. completion2026-09-30
Eligibility
Age20 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06144125

Summary

The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.

Eligibility

Age: 20 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* patients undergoing cardiac surgery

Exclusion Criteria:

* thrombocytopenia
* oral anti-coagulant
* anti platelet agents

Conditions2

Cardiac Valve DiseaseHeart Disease

Interventions2

Fresh Frozen PlasmaProthrombin Complex Concentrate

Related trials

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.